Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis
Completed · Phase 2 · Has a placebo group
Conditions studied: Pruritus, Atopic Dermatitis
In brief
This is a multicenter, randomized, double-blind, 4-arm, placebo-controlled study to evaluate the efficacy and safety of twice-daily (BID) oral difelikefalin (CR845) in adult subjects with atopic dermatitis (AD) and moderate to severe pruritus.
Key facts
- Study ID
- NCT04018027
- Run by
- Cara Therapeutics, Inc.
- People needed
- 401
- Starts
- 2019-06-29
- Expected to finish
- 2021-04-01
- Last updated by the study team
- 2022-04-04
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cara Therapeutics Study Site — Anniston, Alabama, United States
- Cara Therapeutics Study Site — Birmingham, Alabama, United States
- Cara Therapeutics Study Site — Scottsdale, Arizona, United States
- Cara Therapeutics Study Site — Bryant, Arkansas, United States
- Cara Therapeutics Study Site — Fountain Valley, California, United States
- Cara Therapeutics Study Site — Lomita, California, United States
- Cara Therapeutics Study Site — Cromwell, Connecticut, United States
- Cara Therapeutics Study Site — Farmington, Connecticut, United States
- Cara Therapeutics Study Site — Aventura, Florida, United States
- Cara Therapeutics Study Site 2 — Miami, Florida, United States
- Cara Therapeutics Study Site — Miami, Florida, United States
- Cara Therapeutics Study Site — Miami Lakes, Florida, United States
- Cara Therapeutics Study Site — Ocala, Florida, United States
- Cara Therapeutics Study Site — Sarasota, Florida, United States
- Cara Therapeutics Study Site — Sweetwater, Florida, United States
- Cara Therapeutics Study Site — Columbus, Georgia, United States
- Cara Therapeutics Study Site — Boise, Idaho, United States
- Cara Therapeutics Study Site 2 — Boise, Idaho, United States
- Cara Therapeutics Study Site — Baton Rouge, Louisiana, United States
- Cara Therapeutics Study Site — Metairie, Louisiana, United States
- Cara Therapeutics Study Site — New Orleans, Louisiana, United States
- Cara Therapeutics Study Site — Brighton, Massachusetts, United States
- Cara Therapeutics Study Site 2 — Las Vegas, Nevada, United States
- Cara Therapeutics Study Site — Berlin, New Jersey, United States
- Cara Therapeutics Study Site — Horseheads, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.